Image Credit: Vegconomist Announcement Checkerspot, a certified B corporation and a leading biotechnology company that works on renewable oils and fats via the fermentation of microalgae, and Huvepharma, a known leading fermentation and biopharmaceutical company, have entered a commercial-...
Announcement The Biomea Fusion Inc., a leading clinical-level obesity and diabetes company, announced its proposed public offering of securities. The company declared an underwritten public offering of accompanying warrants and shares of its common stock to buy shares of its common stock or...
Image Credit: Manila Bulletin Announcement The United States giant healthcare Bon Secours Mercy Health (BSMH) is extending its operations in the Philippines with its inauguration of a new office purpose-built for the scalability of its served global business services (GBS). The BSMH is a k...
Image Credit: Cleveland Announcement The genialis, a leading RNA biomarker company, has entered a clinical partnership with the Cleveland Clinic, one of the leading academic medical centers, to establish AI-powered tools that will help doctors address the prominent treatment options for pancreat...
Announcement Alpha Cognition Inc., a known marketed stage biopharmaceutical company committed to discovering innovative treatments for neurodegenerative diseases, confirmed its proposed offering and sale of common shares to a few investors, and pre-funded warrants to buy its common shares i...
Image Credit: Yahoo Finance Announcement Recode Therapeutics, a leading clinical-stage genetics medicines company utilizing tissue-specific delivery to strengthen the next generation of gene correction and mRNA therapeutics, has closed above $29 million in additional financing. The company...
Image Credit: PharmaVoice Announcement Eli Lilly and Company inaugurates the new Lilly Gateway Labs (LGL) site in San Diego, California. The company is extending its reach of shared innovation hubs engineered to help early-stage biotechnology companies by availing the opportunities and lab space...
Image Credit: Femasys Inc. Announcement Femasys Inc., a known biomedical innovator making accessible fertility and non-surgical permanent birth control, and has been cost-effective to the women's community globally, has entered a partnership with Kebomed, a popular European medical device and eq...
Image Credit: Oxford University Innovation Announcement Pepgen Inc., a leading clinical-level biotechnology company advancing the next generation future of oligonucleotide therapies with a motive of transitioning the treatment of neurological disease and extreme neuromuscular, declared that they...
Announcement Eli Lilly and Company intends to build a new manufacturing facility worth $6.5 billion at the Generation Park in Houston, Texas. This intensification of the future synthetic medicine active pharmaceutical product (API) facility, one of the second of the four new US sites Lilly will dec...
